OPNT

Opiant Pharmaceuticals, Inc. Common Stock
OPNT

Overview Fund Activity
Delisted

OPNT was delisted on the 1st of March, 2023.

Back to rankings

31 hedge funds and large institutions have $10.2M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.68%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
8
Increased
10
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FM
Fondren Management
Texas
$3.01M
2
SCM
Stonepine Capital Management
Oregon
$3.65M
3
MFIM
Mesirow Financial Investment Management
Illinois
$194K
4
Renaissance Technologies
Renaissance Technologies
New York
$587K
5
AIM
Alambic Investment Management
California
$147K

Top Sellers

1
WCM
Wedge Capital Management
North Carolina
$124K
2
BlackRock
BlackRock
New York
$199K
3
TFA
Tobias Financial Advisors
Florida
$0
4
ASN
Advisory Services Network
Georgia
$38K
5
UBS Group
UBS Group
Switzerland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CAM
26
ClariVest Asset Management
California
$4K +$4K +366 New
OPS
27
Orion Portfolio Solutions
Nebraska
$4K +$4K +450 New
ARMC
28
American Research & Management Company
Massachusetts
$3K – – –
WAP
29
Wealthcare Advisory Partners
Pennsylvania
$1K – – –
Fidelity Investments
30
Fidelity Investments
Massachusetts
$1K +$500 +75 +100%
TFA
31
Tobias Financial Advisors
Florida
– -$39K -2,724 Closed
UBS Group
32
UBS Group
Switzerland
– -$14K -964 Closed
Deutsche Bank
33
Deutsche Bank
Germany
– -$9K -675 Closed
1
2